Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis

Objective: to evaluate the clinical efficiency of tocilizumab (TCZ) versus rituximab (RTM) therapy using DAS 28, SDAI, and CDAI scores and to estimate remission rates using DAS 28 and the remission criteria proposed by the European League Against Rheumatism (EULAR) and the American College of Rheuma...

Full description

Bibliographic Details

Published in:	Научно-практическая ревматология
Main Authors:	Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, E Yu Panasyuk, G V Lukina, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2012-08-01
Subjects:	das 28 sdai cdai rheumatoid arthritis tocilizumab rituximab remission
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1032